Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroids in acute myocardial infarction

C A Bush, W Renner, H Boudoulas

    Angiology
    |October 1, 1980
    PubMed
    Summary

    Methylprednisolone did not improve outcomes for patients with acute myocardial infarction. The study found no benefit in infarct size, heart rhythm, or cardiac function after treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    SU-D-BRCD-05: Evaluation of New Exit Detector Based Transit Dosimetry Software for TomoTherapy Treatments.

    Medical physics·2017
    Same author

    SU-E-T-26: Evaluation of New Pre-Treatment In-Air Patient Specific QA Software for TomoTherapy Treatments.

    Medical physics·2017
    Same author

    LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.

    The pharmacogenomics journal·2015
    Same author

    [Sexually transmitted infections as a cause for solid rectal pseudo tumors].

    Zeitschrift fur Gastroenterologie·2014
    Same author

    Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.

    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2014
    Same author

    Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.

    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2014

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Acute myocardial infarction (AMI) is a leading cause of cardiovascular mortality.
    • Effective treatments to limit infarct size and improve left ventricular function are crucial.

    Purpose of the Study:

    • To investigate the efficacy of methylprednisolone in patients with acute myocardial infarction.
    • To assess the impact of methylprednisolone on infarct size, dysrhythmias, complications, and cardiac function.

    Main Methods:

    • A double-blind, placebo-controlled study involving 42 patients admitted to the Coronary Care Unit with AMI.
    • Patients received either methylprednisolone (30 mg/kg IV every 6 hours for four doses) or a placebo.
    • Outcomes were assessed within 24 hours of symptom onset and at 2 weeks post-infarction.

    Main Results:

    • Methylprednisolone administration showed no significant beneficial effect on infarct size.
    • The drug did not reduce the incidence of dysrhythmias or other complications.
    • Left ventricular function at 2 weeks post-infarction was not improved by methylprednisolone treatment.

    Conclusions:

    • High-dose intravenous methylprednisolone is not effective in improving outcomes for patients with acute myocardial infarction.
    • Current therapeutic strategies for AMI should not include methylprednisolone for infarct size reduction or functional improvement.

    Related Experiment Videos